Acasti Pharma OverviewAcasti Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ACST.
Quarterly EBIT
-$5.62M
↓ 810.7% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$5.62M
↑ 63.45% YoY
Trailing 12 months ending Mar 31, 2026
Acasti Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for ACST.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026